Advertisement
Canada markets close in 3 hours 38 minutes

  • S&P/TSX

    21,757.74
    +101.69 (+0.47%)
     

  • S&P 500

    5,041.48
    +19.27 (+0.38%)
     

  • DOW

    37,944.05
    +190.74 (+0.51%)
     

  • CAD/USD

    0.7268
    +0.0005 (+0.06%)
     

  • CRUDE OIL

    82.74
    +0.05 (+0.06%)
     

  • Bitcoin CAD

    87,422.21
    +3,962.90 (+4.75%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • GOLD FUTURES

    2,399.30
    +10.90 (+0.46%)
     

  • RUSSELL 2000

    1,964.60
    +16.65 (+0.85%)
     

  • 10-Yr Bond

    4.6410
    +0.0560 (+1.22%)
     

  • NASDAQ

    15,739.60
    +56.23 (+0.36%)
     

  • VOLATILITY

    17.48
    -0.73 (-4.02%)
     

  • FTSE

    7,877.05
    +29.06 (+0.37%)
     

  • NIKKEI 225

    38,079.70
    +117.90 (+0.31%)
     

  • CAD/EUR

    0.6816
    +0.0014 (+0.21%)
     
MARKETS LIVE BLOG:

STOCKS RISE AS TECHS REVIVE, WITH NETFLIX EARNINGS ON TAP

Tesla shares slide to 52-week low; stock is down roughly 40% year-to-date

Three COVID-19 vaccines under final review for emergency use - WHO

Reuters
·1 min read

GENEVA, Jan 20 (Reuters) - The World Health Organization (WHO) said on Wednesday that three COVID-19 vaccines were in the late stages of review for possible emergency use listing, in addition to the one made by Pfizer and BioNTech already approved.

An internal WHO document seen by Reuters gives timelines for the agency's possible vaccine approvals, indicating that shots from Moderna, AstraZeneca and China's Sinopharm and Sinovac could win emergency go-ahead in coming weeks or months. "We have one vaccine so far listed. We have 3 more in final phase to be assessed for listing, we have 2 more still submitting...In total we have 13," Mariangela Simao, WHO assistant director-general for access to medicines, vaccines and pharmaceuticals.

The WHO was not aware of any deaths linked to the Pfizer vaccine, nor any other vaccine, she added. (Reporting by John Miller in Zurich and Stephanie Nebehay in Geneva;)